![Jean-Pierre Sommadossi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Pierre Sommadossi
Algemeen Directeur bij
ATEA PHARMACEUTICALS, INC.
Vermogen: 35 M $ op 31-08-2026
Profiel
Dr. Jean-Pierre Sommadossi is Voorzitter bij Kezar Life Sciences, Inc., Voorzitter, President & Chief Executive Officer bij Atea Pharmaceuticals, Inc., Lid-Discovery Council bij Harvard Medical School en Onafhankelijk Bestuurder bij ABG Acquisition Corp. I. Hij zit in de Raad van Bestuur van Rafael Pharmaceuticals, Inc., The BioExec Institute, Inc. en ABG Acquisition Corp. I. Dr. Sommadossi was voorheen werkzaam als Chairman, President & Chief Executive Officer bij Idenix Pharmaceuticals LLC, mede-oprichter bij Pharmasset, Inc., hoogleraar bij de Universiteit van Alabama in Birmingham, Fogarty Fellow bij het Medical College of Virginia, Fogarty Fellow bij het National Cancer Institute, en adviseur bij Puretech Health LLC. Hij was ook lid van de raad van bestuur van Alzheon, Inc. en Kinex Pharmaceuticals, Inc. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Marseille.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-04-2026 | 6.633.855 ( 8,27% ) | 35 M $ | 31-08-2026 |
Actieve functies van Jean-Pierre Sommadossi
| Bedrijven | Functie | Begin |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Algemeen Directeur | 01-12-2012 |
| ABG ACQUISITION CORP. I | Directeur/Bestuurslid | 01-02-2021 |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Directeur/Bestuurslid | 01-01-2004 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Voorzitter | 01-01-2015 |
Eerdere bekende functies van Jean-Pierre Sommadossi
| Bedrijven | Functie | Einde |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Voorzitter | 11-05-2022 |
Pegaone GmbH
 Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Voorzitter | 01-01-2021 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2021 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Directeur/Bestuurslid | 01-11-2020 |
| ATHENEXPAR | Directeur/Bestuurslid | 01-07-2014 |
Opleiding van Jean-Pierre Sommadossi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
17
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 17 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Marseille
 University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Pegaone GmbH
Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
ABG Acquisition Corp. I
 ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
